Madrigal Pharmaceuticals, Inc. Share Price
NASDAQ: MDGL | Large CapMadrigal Pharmaceuticals, Inc. Stock Performance
Madrigal Pharmaceuticals, Inc. Share Price Today
As of 15 September 2026, Madrigal Pharmaceuticals, Inc.'s share price is $539.71. The stock opened at $533.50, compared to its previous close of $535.39. During today's trading session, Madrigal Pharmaceuticals, Inc.'s share price traded between $529.01 and $540.90, with an average price of $534.96. Over the past 52 weeks, the stock has recorded a high of $614.13 and a low of $393.82. In terms of performance, Madrigal Pharmaceuticals, Inc.'s share price has risen by 3.16% over the last six months and is up 17.69% on a year-on-year basis.
Madrigal Pharmaceuticals, Inc. Share Price Chart
Madrigal Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Madrigal Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.
Madrigal Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $544.35 | $535.39 | -1.48% |
Aug 2026 | $468.70 | $543.45 | +16.19% |
Jul 2026 | $535.50 | $467.72 | -12.88% |
Jun 2026 | $494.44 | $536.85 | +8.03% |
May 2026 | $514.33 | $496.94 | -3.79% |
Apr 2026 | $544.66 | $516.53 | -1.27% |
Mar 2026 | $429.31 | $523.17 | +21.08% |
Feb 2026 | $486.09 | $432.09 | -11.58% |
Jan 2026 | $582.02 | $488.67 | -16.10% |
Dec 2025 | $591.94 | $582.42 | -2.46% |
Nov 2025 | $420.95 | $597.12 | +42.47% |
Oct 2025 | $462.01 | $419.13 | -8.60% |